Check-Up-Medizin

Autor: D. Abeck, S. Wärntges, M. Oeff, A. Ernst, B. Dannewitz, W. J. Kox, P. Cullen, H.J. Greten, T. Hinrichs, C.-M. Muth, N. Worm, E. Stapelfeldt, H. Drexler, F. Mußhoff, Uwe Nixdorff, W. Jilg, J. Siegrist, B. Madea, H. Mück, S. Schirp, F. Wagner, F.-M. Köhn, G. Kluge, K. Kraft, G. Mehlhorn, M. Mück-Weymann, R. Gerzer, D. Domagk, J. Pantel, C. Gawrilow, C. M. Bamberger, K. Riemann, G. Michelson, R. Schulz-Wendtland, P. Sefrin, J. Wessling, H. Rübben, M. Möhrenschlager, M. Hensel, G. Schulz, Y. K. Maratos, M. Halle, K. Tetzlaff, E. Gramenz, G. Jacobi, U. Nixdorff, W. Blank, V. Tesky, F. Kiefer, W. Kindermann, P. Platen, P. Eickholz, L.S. Griffith, H. C. Diener, S. Schwarz, H. Binder, J. H. Ficker, D.H.W. Grönemeyer, T. H. Fink, B. Meurer, E. Stockmann, J. Mutschler, M. W. Beckmann

Publikováno v: Check-Up-Medizin: Prävention von Krankheiten – Evidenzbasierte Empfehlungen für die Praxis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::151c7c769c5946f002e6457853a74ef7
https://doi.org/10.1055/b-002-39788

Monochemotherapy vs. doublet vs. triplet chemotherapy (CTX) with predefined sequence for 2nd-line therapy in stage IIIb and IV NSCLC: A randomised phase III trial

Autor: C. Klose, T. H. Fink, U. Seifart, Juergen R. Fischer, E. Jäger, P. Schiller, Martin Wolf, L. J. Müller

Publikováno v: Journal of Clinical Oncology. 26:19008-19008

19008 Background: The optimal intensity of CTX for palliative treatment in stage IIIb/IV NSCLC is still unclear. We initiated a prospective, randomised phase III trial comparing mono vs. doublet vs...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f03e0d9e4c5694a03c2b40dd1db2d855
https://doi.org/10.1200/jco.2008.26.15_suppl.19008

Phase II study of cisplatin, etoposide and concurrent radiation therapy with maintenance chemotherapy with cisplatin and gemcitabine for unresectable non-small cell lung cancer

Autor: T. H. Fink, Vratislav Strnad, Rolf Sauer, J. H. Ficker, W. Melzner

Publikováno v: Journal of Clinical Oncology. 22:7290-7290

7290 Background:This phase II study has been conducted to determine the feasibility, toxicity, response rate, local control, distant metastases, and survival of concurrent chemotherapy with etoposi...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::22be0cf6f40eef2bc63e3dde43bb5cf7
https://doi.org/10.1200/jco.2004.22.90140.7290